KWS BioTest is an established contract research organisation that brings together internationally renowned scientific expertise in a commercially managed environment for the testing of prophylactic and therapeutic agents as treatments for human disease.
Formed in 2004, KWS BioTest originates from the University of Bristol, and operates in state of the art facilities focused on contract research. The ability to bring academic expertise into a dedicated contract research environment allows KWS BioTest to provide an unrivalled expertise in preclinical pharmacology and drug development.
The company has grown year on year since forming in order to serve an ever increasing list of clients, most of whom have come back for further work. Since beginning as a specialist in autoimmunity and infection, KWS has expanded its offering to provide a wide range of assays and models in areas spanning inflammation, allergy, neurodegenerative disease, pain, proteomics and protein biochemistry. KWS BioTest invests in an extensive research and development pipeline with the aim of innovating and validating new services and models.